Abstract Alcoholic liver disease is a major biomedical health concern in the United States. Despite considerable research efforts aimed at understanding the progression of the disease, the specific mechanisms leading to alcohol-induced damage remain elusive. Numerous proteins are known to have alcohol-induced alterations in their dynamics. Defining these defects in protein trafficking is an active area of research. In general, two trafficking pathways are affected: transport of newly synthesized secretory or membrane glycoproteins from the Golgi to the basolateral membrane and clathrin-mediated endocytosis from the sinusoidal surface. Both impaired secretion and internalization require ethanol metabolism and are likely mediated by acetaldehyde. Although the mechanisms by which ethanol exposure impairs protein trafficking are not fully understood, recent work implicates alcohol-induced modifications on tubulin or components of the clathrin machinery as potential mediators. Furthermore, the physiological ramifications of impaired protein trafficking are not fully understood. In this review, we will list and discuss the proteins whose trafficking patterns are known to be impaired by ethanol exposure. We will then describe what is known about the possible mechanisms leading to impaired protein trafficking and how disrupted protein trafficking alters liver function and may explain clinical features of the alcoholic patient.
Introduction
For over 30 years, defining the alcohol-induced defects in protein trafficking has been an active area of research in understanding liver injury. To date, numerous proteins are known to have alcohol-induced alterations in their dynamics. In general, two transport pathways appear to be affected: transport of newly synthesized secretory or membrane glycoproteins from the Golgi to the basolateral membrane and clathrin-mediated endocytosis from the sinusoidal surface. In this review, we will first list and discuss hepatic proteins whose trafficking is known to be impaired by ethanol exposure. We will then describe our current understanding of the mechanisms and physiological consequences of impaired protein trafficking.
Ethanol-induced impairment of biosynthetic protein trafficking
Over three decades ago, it was reported that ethanol exposure led to defects in protein secretion. Since then, many researchers have confirmed these results in numerous model systems by monitoring bulk secretion with radiolabeled proteins or by monitoring the fates of specific molecules (Table 1) . These early studies also determined that plasma membrane delivery of newly synthesized transmembrane proteins was impaired upon ethanol exposure leading to altered surface composition (Table 2) . In this section, we will briefly describe these early experiments and highlight some important findings.
Ethanol-induced impairment of constitutive secretion
The liver synthesizes the majority of serum proteins and lipoproteins and is characterized by robust constitutive secretion from the basolateral surface. In general, proteins destined for the secretory pathway encode a signal sequence that directs their docking and cotranslational entry into the endoplasmic reticulum (ER). During transit through the ER, secretory proteins are step-wise glycosylated, properly folded and eventually packaged into coatomer II-coated vesicles for delivery to the cis-Golgi. During transit through the Golgi, the secretory proteins are further modified (e.g., sulfation or phosphorylation) and their carbohydrates further trimmed and modified. In the trans-Golgi network (TGN), the newly synthesized proteins are terminally glycosylated by the addition of N-acetylglucosamine, galactose, sialic acid and/or fucose moieties. While the mechanistic details regulating sorting at the TGN are not fully understood, secreted proteins are packaged into discrete vesicles, delivered to the basolateral surface and released [75] . In general, surface delivery of secretory proteins is a microtubule-dependent process that is mediated by a host of other molecules [20, 53, 69, 72] . In this section, we will describe alcohol-induced defects in bulk secretion and in the secretion of specific molecules.
Bulk secretion
To investigate ethanol's effects on protein secretion, early studies examined bulk secretion of radiolabeled leucine incorporated into newly synthesized proteins in both the rat liver and liver slices [2, 83, 94, 100, [106] [107] [108] . Both acute and chronic ethanol exposure induced a significant decrease in secreted levels of 14 C/ 3 H-leucine-labeled proteins (35-40%) in both systems (Table 1 ). This decrease in secretion correlated with a reciprocal increase in hepatic protein content indicating that the alcohol-induced secretion defect was not due to altered protein synthesis. From studies using differential centrifugation to isolate intracellular organelles, it was further determined that the bulk of hepatic secretory proteins was retained in the Golgi in ethanol-treated hepatocytes suggesting a block in vesicle delivery from the TGN to the basolateral surface ( Fig. 1 ) [108] .
To further pinpoint where the block in secretion was occurring, newly synthesized proteins were also labeled with 14 C-glucosamine (added in the ER), 14 C/ 3 H-fucose or 14 C-galactose (both added in the TGN) [16, 81-83, 94, 100, 106-108] . A similar impairment in secretion was seen for all three labels along with a corresponding increase in intracellular protein content. Since the majority of 14 C/ 3 Hfucose-labeled proteins accumulated in the Golgi and there were no changes in total glycosylation, the authors concluded that alcohol impaired post-Golgi sorting and vesicle delivery [16, 107, 108] . Additional studies performed in isolated hepatocytes [3] confirmed these results indicating that the ethanol-induced impairment of bulk secretion was highly reproducible and independent of the system used ( Table 1) . ASGP-R Chronic Rat liver [11, 12] EGF-R Chronic Isolated hepatocytes [18] Addition of acetaldehyde also led to impaired hepatic secretion indicating that ethanol metabolism is required for the defect [106] . This is consistent with findings where addition of cyanamide (an aldehyde dehydrogenase (ALDH) inhibitor that leads to increased acetaldehyde levels) potentiated the impairment, while 4-methyl pyrazole (4-MP) (an alcohol dehydrogenase (ADH) inhibitor that leads to decreased acetaldehyde levels) prevented the observed secretion defects [83, 106, 107] . Together, these early studies indicate that ethanol significantly impairs hepatic protein secretion, and the defect is likely mediated by acetaldehyde.
Albumin
Serum albumin is a plasma protein that is synthesized and secreted in high quantities by hepatocytes. In the blood, albumin plays an important role in the maintenance of osmotic pressure and serves as a carrier for small hydrophobic molecules including hormones and unconjugated bilirubin [28] . Because decreased serum albumin levels can be associated with liver injury, it was of particular interest to directly determine whether alcohol exposure led to impaired albumin secretion. Chronic ethanol exposure in rats led to a significant increase in hepatic retention of both albumin and its precursor form, proalbumin, with a reciprocal decrease in secretion (Table 1) [2, 94] . More recent studies in both rat liver slices and polarized, hepatic WIF-B cells have also determined that ethanol exposure impairs albumin secretion (Table 1) [35, 38] . As for bulk secretion, addition of 4-MP to precision cut liver slices prevented the impairment, indicating that the defect requires ethanol metabolism and is likely mediated by acetaldehyde [38] .
Other secreted molecules
Early findings in primary hepatocytes indicated that acute ethanol treatment also impairs 14 C-glycerol labeled glycerolipid secretion that correlates with an increase in hepatic glycerolipid formation (triglycerides) ( Table 1 ) [111] . Additional studies identified that both acute and chronic ethanol exposure impaired VLDL secretion in rat livers and primary hepatocytes [27, 37, 40, 104] . These findings correlated with an increase in hepatic triglycerides, suggesting a possible mechanism for the clinically observed fatty liver. Chronic ethanol treatment in isolated hepatocytes has also been shown to impair hepatic triglyceride lipase secretion, while both acute and chronic treatment impairs IGF-1 secretion, the latter of which is prevented by the addition of 4-MP [64, 67, 113] . Also, studies examining transferrin processing and secretion noted increased hepatic transferrin in the Golgi of both rats and humans with alcoholic liver disease [2, [47] [48] [49] . This correlated with decreased transferrin secretion and altered glycosylation, the latter of which serves as a marker for patients with alcoholic liver disease. Together, it is clear that ethanol induces significant defects in hepatic secretion (Table 1) and impaired secretion requires ethanol metabolism and is likely mediated by acetaldehyde.
Ethanol-induced alterations in plasma membrane composition
The basolateral plasma membrane is characterized by a specific complement of lipids and proteins not only required for membrane structure and integrity, but also for proper function. Although the details by which membrane proteins are sorted and delivered to the basolateral plasma membrane are still emerging, the newly synthesized membrane-bound glycoproteins are transported through the same biosynthetic compartments and are similarly glycosylated and processed as secretory proteins [20, 53, 69, 72] . Because of this similarity and the importance of this pathway, studies have examined the effects of ethanol on basolateral membrane delivery. In this section, we will briefly describe the known impairments in this process ( Table 2) .
Bulk membrane delivery
To investigate ethanol's effects on basolateral membrane biogenesis, early studies examined bulk delivery of newly synthesized 14 C-fucose-or 3 H-N-acetyl mannosamine (a Fig. 1 Alcohol-induced defects in hepatic trafficking. Secretion and delivery of newly synthesized basolateral proteins is impaired in ethanol-exposed hepatocytes (step 1). Also, three major steps in the itineraries of various receptors are impaired by ethanol metabolism: transport of newly synthesized receptors from the Golgi to the basolateral membrane (step 1); receptor internalization from the plasma membrane (step 2); and recycling of receptors from recycling endosomes (RE) back to the cell surface (step 3). EE early endosome; RE recycling endosome; lys lysosome; BC bile canaliculus Genes Nutr (2010) 5:129-140 131 sialic acid precursor)-labeled glycoproteins [46, 96] . As for secretory proteins, the delivery of membrane glycoproteins was impaired in ethanol-treated hepatocytes with a reciprocal increase in intracellular protein content ( Fig. 1 ) [46, 96] . To confirm that ethanol exposure altered basolateral membrane composition, concanavalin A (ConA) binding assays were performed [58] . Importantly, this lectin has a high affinity for glucose and mannose residues that are enriched on basolateral glycoproteins. Consistent with impaired glycoprotein delivery, less ConA surface labeling was observed for isolated hepatocytes from chronically fed animals [58] indicating altered plasma membrane composition. Also consistent with these results are the findings that decreased levels of newly synthesized receptors (Table 2) were detected at the plasma membrane in ethanol-exposed hepatocytes [11, 12, 18, 41] . Together, these results indicate that ethanol impairs basolateral delivery of glycoproteins; however, it is not yet known whether the defect requires ethanol metabolism, studies that are likely forthcoming.
Ethanol-induced impairment of clathrin-mediated endocytosis
Endocytosis serves as the interface between the cell and its external environment and is vital to many cellular processes including intercellular communication, nutrition, cell motility and signal transduction. Endocytosis includes several diverse mechanisms by which molecules are internalized at the plasma membrane and are packaged into discrete transport vesicles. There are at least three major internalization routes in mammalian cells: clathrin-mediated, caveolae/raft-mediated and non-clathrin/non-raft mediated [15, 21, 52] that are characterized by specific molecular players, cargoes and regulators. In general, the ligands and receptors that display alcohol-induced internalization defects are internalized via clathrin-mediated pathways (Table 3 ). In contrast, internalization of markers of caveolae/raft-mediated and fluid phase endocytosis and non-vesicle-mediated uptake are not changed by ethanol exposure. In this section, we will list and discuss which ligands, receptors and other markers have been examined for defects in endocytosis.
ASGP-R
Much of our understanding of the alcohol-induced defects in endocytosis comes from studies examining the trafficking of asialoglycoproteins (ASGP) and their receptor, the ASGP receptor (ASGP-R), in control and ethanol treated hepatic cells (Fig. 1 ). After synthesis, ASGP-R is delivered to the basolateral plasma membrane where it is available to bind circulating ligands. Upon ligand binding, the receptorligand complex is internalized via clathrin-mediated endocytosis and is delivered to early endosomes. The ligand-receptor complex is then delivered to recycling endosomes where the ligand dissociates due to the acidic environment. The ligand is then transported to the lysosome for degradation, while the receptor recycles back to the basolateral plasma membrane for further rounds of ligand binding (Fig. 1) . At least three steps in the itinerary of ASGP-R have been shown to be impaired by ethanol metabolism: transport of newly synthesized ASGP-R from Hemagglutinin Chronic WIF-B [24] the Golgi to the basolateral plasma membrane, receptor internalization from the basolateral plasma membrane, and recycling of the receptors from recycling endosomes back to the cell surface ( Fig. 1 Other well-characterized receptors
The clathrin-mediated internalization of a number of other well-characterized receptors has also been shown to be impaired by ethanol exposure (Table 3) . For example, transferrin via the transferrin receptor has been shown to be impaired in isolated rat hepatocytes after acute ethanol treatment, while internalization of transferrin receptor has been shown to be impaired in WIF-B cells after chronic treatment (Table 3 ) [4, 24] . As for ASGP-R, addition of 4-MP to rat hepatocytes prevented impaired transferrin receptor internalization, suggesting that the defect requires ethanol metabolism. The internalization of two other known clathrin-mediated endocytosis markers, polymeric IgA receptor and chylomicron remnants via the LDLreceptor, was also shown to be impaired in ethanol-treated WIF-B cells or rat hepatocytes, respectively [24, 39] . Together, these results indicate that the well-described internalization defect of ASGP-R is not specific to that receptor, but rather is a general result of impaired clathrinmediated endocytosis (Fig. 1) .
Cytokines, growth factors and hormones
The internalization and/or serum clearance of many cytokines, growth factors, and hormones has been shown to be impaired by ethanol consumption. The list so far includes: TGF-a, TNF-a, IL-6, EGF, and insulin (all in rat hepatocytes), growth hormone and insulin (in cirrhotic patients), and glucagon (in isolated rat liver plasma membranes) (Table 3 ) [10, 18, 62, 63, 71, 91, 99] . Remarkably, most of these molecules are known to be internalized by clathrinmediated endocytosis [8, 9, 23, 61, 73, 80, 88, 103, 105, 109] . At present, it is not well established whether the impaired internalization of these various ligands requires ethanol metabolism, but based on the receptor defects described earlier, the prediction is that it does. Together, these results suggest that it is not the receptors themselves that are altered by ethanol metabolism, but rather it is a general regulator of clathrin-mediated internalization that is altered.
Other internalization pathways are not impaired by ethanol exposure
In general, fluid-phase endocytosis and caveolae/lipid raftmediated internalization are not likely impaired by ethanol exposure. Although not as extensively studied as clathrininternalized receptors and ligands, there are a handful of studies that have examined markers of other internalization routes. For example, in both rat livers and WIF-B cells, the fluid phase internalization of Lucifer yellow was not changed by ethanol treatment [5, 24] . Similarly, the internalization of the GPI-anchored protein, 5 0 nucleotidase (5 0 NT), and of the cholera toxin B subunit (markers for raft-mediated internalization) was not changed in ethanoltreated WIF-B cells [24, 35] . Furthermore, the non-vesicle, non-raft mediated internalization of fluorescein diacetate was not changed in ethanol-treated WIF-B cells [24] . Together, these results indicate that ethanol exposure selectively impairs clathrin-mediated endocytosis.
Mechanisms responsible for impaired protein trafficking
Ethanol is metabolized via two pathways: ADH-mediated or cytochrome P450 2E1 (CYP 2E1)-mediated. ADHmediated metabolism results in the production of acetaldehyde, a highly reactive intermediate that can form stable, covalent modifications on other macromolecules [89] . CYP 2E1-mediated ethanol metabolism not only leads to the formation of acetaldehyde, but also to the formation of oxygen and hydroxyethyl radicals that in turn promote the formation of other highly reactive intermediates [89] . Like acetaldehyde, many of these CYP 2E1-generated byproducts can form stable, covalent modifications on proteins, lipids, DNA and other macromolecules [89] . Thus, one hypothesis for alcohol-induced hepatotoxicity is that the accumulated covalent modifications from chronic alcohol consumption disrupt the normal function of hepatic proteins, lipids and DNA leading to hepatocyte dysfunction and liver injury. More recently, it has become apparent that alcohol exposure induces protein covalent-modifications that are part of the natural repertoire. To date, these posttranslational modifications include increased methylation, phosphorylation and acetylation [36, 43, 45, 65, 66, 68, 115] . In particular, numerous proteins have been identified that are hyperacetylated upon ethanol exposure, and this list is expanding rapidly [78] . As for adduct formation, it is not clear how increased acetylation is related to the progression of hepatotoxicity. In this section, we will discuss how modifications on tubulin or components of the clathrin machinery may contribute to alcohol-induced defects in protein trafficking.
Ethanol-induced tubulin modifications
Many proteins can be modified by acetaldehyde, including tubulin, actin, calmodulin, hemoglobin, hepatic enzymes and plasma proteins [31, 50, 51, 57, 84, 112] . In general, acetaldehyde is thought to form stable adducts with the e-amino group of lysine residues [93, 95, 97] . One of the best-studied target proteins for acetaldehyde adduction is a-tubulin [97] . In vitro, this protein was found to be preferentially modified on a highly reactive lysine (probably lysine 394) [85, 86] in a time and concentration dependent manner [32, 33] . In vitro polymerization assays using low acetaldehyde:tubulin dimer levels further revealed that adduction drastically impaired microtubule formation [34] . This impairment occurred at substoichiometric amounts of acetaldehyde (0.2 mol acetaldehyde/mol tubulin) [79] suggesting that low levels of adduction can have far reaching effects on microtubule function. The defect in tubulin polymerization was also examined in isolated hepatocytes from alcohol-fed rats [114] . After removing nocodazole (a reversible, microtubule depolymerizing agent), microtubule regrowth was found to be significantly impaired in ethanol-treated hepatocytes consistent with impaired polymerization seen in vitro. Ethanol-treated WIF-B cells exhibited a similar tubulin phenotype where microtubule regrowth after nocodazole washout was impaired [36] .
Steady state microtubules in alcohol-treated WIF-B cells were also found to be more stable and acetylated 2-3-fold more than in control cells [36] . This post-translational modification is characteristic of stable microtubule populations [110] . These results were confirmed in livers from ethanol-fed rats and in ethanol-treated liver slices indicating that the findings have physiologic importance [36] . Because microtubule hyperacetylation is prevented by 4-MP (in WIF-Bs and liver slices) and potentiated by cyanamide (in WIF-Bs), increased acetylation and stability require alcohol metabolism and are likely mediated by acetaldehyde. Thus, ethanol metabolism impairs tubulin polymerization, but once microtubules are formed they are hyperstabilized.
Because many vesicle transport steps are microtubule dependent, alterations in microtubule dynamics will likely contribute to defects in protein trafficking. Although the precise relationship between acetaldehyde modified-tubulin and defects in protein trafficking is not known, a link between tubulin acetylation and defects in protein trafficking is emerging. There is evidence that different microtubule populations (and/or their modifications) support specific protein trafficking steps [60] . Of particular interest are studies performed in WIF-B cells that used a novel microtubule depolymerizing drug, 201-F [70] . This drug specifically depolymerizes dynamic microtubules leaving only stable, acetylated polymers behind. In 201-Ftreated WIF-B cells, both secretion and transcytosis were impaired.
These results prompted us to test whether the defects in secretion and endocytosis observed in ethanol-treated cells can be explained by increased microtubule acetylation and stability. To do this, we examined the trafficking of selected proteins in WIF-B cells treated with ethanol or trichostatin A (TSA), a potent inhibitor of histone deacetylases (HDACs), including HDAC6. HDAC6 is the major tubulin deacetylase in liver and WIF-B cells [26, 77] and when inhibited with TSA increased microtubule acetylation and stability is observed in the absence of ethanol [35] . As shown in ethanol-treated cells, clathrin-mediated internalization of ASGP-R and APN was impaired in TSAtreated cells, while raft/caveolae-mediated internalization of the GPI-anchored protein, 5 0 NT, was not changed [35] . Also as in ethanol-treated cells, albumin secretion was inhibited by TSA [35] . These results combined with the remarkable similarity of our findings in ethanol or TSA treated cells with 201-F-treated cells lead us to conclude that increased microtubule acetylation and stability explain, in part, the alcohol-induced defects in protein trafficking.
Ethanol-induced modifications of the clathrin machinery
Clathrin-mediated internalization is a highly regulated process involving multiple proteins [for reviews see 15, 21, 42, 52, 53] . In general, clathrin triskelions are recruited to and assembled at regions of the plasma membrane enriched in PIP 2 . Adaptor protein (AP) complexes, such as AP2, are targeted to the membrane by their a-adaptin subunits and interact directly with sorting signals on internalized proteins (usually containing di-leucine or tyrosine-based motifs) via their l2 subunits. The large GTPase, dynamin, is thought to be recruited and assembled on the necks of coated pits where it likely mediates membrane fission and vesicle release. The released vesicles are rapidly uncoated allowing for coat recycling and vesicle fusion with its target organelle.
At present, the specific mechanisms responsible for ethanol-induced defects in clathrin-mediated internalization are not known. Because the clathrin-mediated internalization of many unrelated proteins is impaired in situ, in isolated hepatocytes and in ethanol-treated WIF-B cells (Table 3) , it is likely that a universal regulator of clathrinmediated internalization is impaired, not the receptors themselves. This is consistent with recent findings where clathrin heavy chain accumulates at the basolateral membrane in discrete puncta in ethanol-treated WIF-B cells [24] suggesting impaired vesicle budding. Additionally, dynamin-2 was found to be less tightly associated with membranes in ethanol-treated cells, further suggesting that vesicle fission was impaired. However, it is not clear what promotes basolateral accumulation of clathrin heavy chain or decreased dynamin membrane associations. Because impaired ASGP-R clathrin-mediated internalization required ethanol metabolism and is likely mediated by acetaldehyde [35] , an exciting possibility is that the molecular machinery that drives clathrin-mediated endocytosis is more prone to adduction by acetaldehyde or other reactive metabolites than the molecules regulating other internalization routes. Clearly, this exciting hypothesis requires more research.
A similar scenario may also evolve for proteins involved in vesicle budding and fission from the TGN. Basolateral resident proteins contain targeting information that likely promotes their recruitment into clathrin-coated vesicles at the TGN [72] . These basolateral targeting signals are similar to the signals required for clathrin-internalization and the majority are either tyrosine-based or contain a di-leucine motif [72] . Thus, one exciting possibility is that an alcohol-induced modification of the clathrin machinery also leads to defective vesicle fission at the TGN. Although constitutive secretory proteins are thought to bud from the TGN in different vesicle populations than transmembrane proteins [74] , it is not yet clear what factors are required for their formation. Because constitutive secretion is also impaired in ethanol-treated hepatic cells, one possibility is that at least some components of the clathrin machinery are shared, and that these components are readily modified by reactive alcohol metabolites. Clearly, this is a fertile area of investigation for future research.
Another possibility is that key components of the clathrin machinery may be hyperacetylated upon ethanol exposure leading to impaired internalization. Although this hypothesis is untested, it is supported by the findings that actin and cortactin, two members of the clathrin machinery, are known to be hyperacetylated in the presence of ethanol [78] . Both of these proteins regulate late stages of clathrin coated vesicle budding from the plasma membrane and the TGN [6, 7] . In general, cortactin is thought to promote actin polymerization at sites of vesicle formation and recruit dynamin to the necks of budding vesicles [6, 7] . At present, the exact mechanism by which cortactin, actin and dynamin function to promote vesicle release is not yet completely elucidated. However, acetylation of cortactin is known to prevent its association with actin [116] . From these results, we propose that alcohol-induced hyperacetylation leads to decreased interactions between actin and cortactin such that cortactin is no longer recruited to sites of clathrin-vesicle formation, thereby inhibiting dynamin recruitment and subsequent vesicle fission. We are currently testing this exciting possibility.
Clinical implications of impaired protein trafficking
In this section, we describe the possible clinical relevance of alcohol-induced alterations in protein trafficking. We first describe possible ramifications of impaired secretion and basolateral delivery of newly synthesized membrane proteins. We end with discussing how alterations in clathrin-mediated internalization may explain the altered levels of circulating molecules in the alcoholic patient, and how impaired internalization might explain some alcoholinduced nutritional deficiencies.
Impaired secretion may be related to hepatomegaly and fatty liver Defects in post-Golgi transport have been associated with hepatomegaly, a common phenotype of early alcoholic liver disease. In the alcohol-exposed liver, newly synthesized hepatic secretory proteins, lipoproteins and lipids accumulate in the Golgi, leading to increased cellular content. Furthermore, increased protein levels are exacerbated by alcohol-induced decreases in lysosomal and proteosomal protein degradation [22] . Based on these observations, the hypothesis is that the increased cellular protein and lipid content lead to increased hepatocyte volume [90, 92, 98] . This in turn leads to the clinically observed hepatocyte ''ballooning'' that may cause increased hepatic pressure or more serious liver injury. Furthermore, increased cellular lipoproteins and the decreased secretion of glycerolipids have also been correlated to increased hepatic triglyceride accumulation, a hallmark of ethanol-induced fatty liver, another early stage of alcohol-induced injury.
Defects in hepatic secretion may also be responsible for changes in the levels of circulating macromolecules in the alcoholic patient. As discussed earlier, hepatocytes are responsible for the synthesis and delivery of the majority of plasma proteins and lipoproteins. As summarized in Table 1 , the secretion of many of these proteins is known to be impaired by ethanol exposure including albumin, transferrin and coagulation factors. Thus, defects in secretion may lead to altered blood buffering and blood volume, iron delivery to peripheral tissues and clotting defects. Similarly, impaired biliary delivery of newly synthesized glycoproteins has been reported in ethanol-fed rats, which in turn might explain, in part, decreased bile production observed in the alcoholic liver [44, 59] .
Decreased bile production has further been implicated in impaired absorption of dietary lipids observed in the alcoholic patient [101] .
Impaired basolateral delivery alters membrane composition and function Impaired surface delivery of newly synthesized membrane glycoproteins and lipids ultimately leads to changes in the lipid and protein composition of the basolateral membrane. Such changes in membrane content may have serious ramifications not only on membrane integrity and permeability, but also on membrane function. For example, the failure to properly deliver cell surface transporters may have far-reaching implications on ion homeostasis. Similarly, the failure to properly deliver surface receptors could lead to harmful alterations in diverse cellular processes ranging from nutrition to signal transduction.
Impaired clathrin-mediated internalization likely alters numerous hepatic processes
Chronic alcohol consumption leads to many nutritional side effects. Much of this is due to the fact that an alcoholic often substitutes the calories from ethanol for the calories from food such that he/she becomes malnourished [44, 59] . This is further exacerbated by the decreased intestinal absorption of many compounds including dietary fats, fat soluble vitamins, essential amino acids, folic acid, glucose and minerals such as calcium, zinc, iron and magnesium [101] . In general, these defects are not likely due to impaired clathrin-mediated endocytosis. Most fat soluble vitamins associate with bile acid micelles and enter passively across the membrane, while most minerals are absorbed paracellularly or through specific transporters (e.g., copper and zinc). Thus, decreased absorption may be due to decreased bile production (for dietary fats and fatsoluble vitamins) or decreased paracellular permeability (for minerals). However, there are some nutritional deficiencies that might be explained by impaired clathrinmediated internalization that are described in this section. Furthermore, there are some interesting examples of molecules that are increased in the alcoholic's circulation, yet their biologic responses are diminished or absent. We propose that this paradox may also be explained by impaired clathrin-mediated internalization as described in the following paragraphs.
Vitamin B 12 and fat soluble vitamins
Many alcoholics display serious vitamin B 12 deficiencies [44, 59] . Unlike many other hydrophobic vitamins, B 12 is internalized via clathrin-mediated mechanisms in the intestine, liver and kidney [101] . In the small intestine, vitamin B 12 associates with intrinsic factor, a small glycoprotein synthesized and secreted by gastric parietal cells [101] . The B 12 -intrinsic factor complex binds enterocytes via its receptor, cubilin, which in turn is complexed to the transmembrane protein, megalin [101] . The entire B 12 -intrinsic factor-cubilin-megalin complex is then internalized in clathrin-coated vesicles [101] . Ultimately, the B 12 is secreted into the circulation coupled to transcobalamin II [101] . Peripheral tissues (mainly the liver and kidney) bind the B 12 -transcobalamin II complexes via transcobalamin II receptors, and the whole assembly is internalized in clathrin-coated vesicles. Thus, the vitamin B 12 deficiencies seen in alcoholic patients may be explained, in part, by impaired clathrin-mediated endocytosis. This interesting hypothesis clearly requires further consideration.
Although vitamins A and D are absorbed passively across most cell membranes in association with lipid micelles, there is an interesting scavenge mechanism operating in kidney proximal tubules [101] . These vitamins are retrieved from the urine by association with surfaceassociated megalin. As described earlier for vitamin B 12 , the megalin-A or -D complexes are internalized in clathrincoated vesicles. Thus, one interesting prediction is that this clathrin-mediated scavenge mechanism is impaired in chronic alcoholics. However, it remains to be determined whether ethanol consumption impairs clathrin-mediated endocytosis in other cell types.
Cytokines and growth factors
As summarized in Table 3 , the internalization of a host of cytokines and growth factors is known to be impaired in ethanol-treated hepatic cells or in livers from ethanol-fed rats. Remarkably, the majority of these molecules are internalized by clathrin-mediated mechanisms. Furthermore, many of these growth factors and cytokines are present in increased amounts in the alcoholic patient's circulation, yet their biologic effects are diminished [44, 59] . One such interesting paradox has been described for signaling via the TNF-a and IL-6 pathways [reviewed in 29, 30] . The circulating levels of each of these cytokines are increased in alcoholic patients and in ethanol-fed animals [29, 30] where they exert proinflammatory responses. However, both of these ligands are also known to promote hepatoprotective activities and are required for liver regeneration [25, 29, 30, 87] . The puzzle is why the hepatoprotective and hepatomitogenic effects of TNF-a and IL-6 are selectively lost in alcohol-treated hepatocytes despite their high circulating levels. One possible explanation for impaired hepatic signaling is defects in IL-6 and TNF-a receptor internalization. The simple hypothesis is that decreased cytokine retrieval leads to decreased signaling, and thus, decreased hepatoprotection. Because alcohol-induced defects in basolateral delivery of the newly synthesized receptors and receptor recycling also lead to decreased cell surface receptor numbers (Fig. 1 ) [54] , another intriguing hypothesis is that one or both of these steps is impaired in the receptors' itineraries. Clearly, these hypotheses need to be tested for IL-6, TNF-a and other signaling molecules.
ASGP-R and apoptosis
Apoptosis, or programmed cell death, is an irreversible process whereby cells respond to either intrinsic or extrinsic signals that initiate cascades that lead to cell death. Ultimately, the apoptotic cell is fragmented into apoptotic bodies that are then internalized and degraded by neighboring cells. Recent work has suggested that the surfaces of apoptotic bodies are enriched in desialated glycoproteins, and that ASGP-R binds these desialated carbohydrates and mediates apoptotic fragment internalization and degradation [19, 55] . More recently, it has been discovered that increased apoptotic bodies are present in alcohol-exposed livers and that their internalization is impaired by 40-60% [19] . Thus, one interesting hypothesis is that alcohol-induced alterations in protein trafficking are responsible for the impaired clearance of apoptotic bodies. Furthermore, addition of apoptotic bodies to cultured Kupffer cells have been shown to stimulate secretion of the proinflammatory cytokines, TNF-a and IL-6 [56] . These results suggest that decreased apoptotic body clearance in livers promote an inflammatory response leading to enhanced liver injury, a hypothesis that will be interesting to test.
Conclusion and future directions
From the work summarized here, it is clear that chronic alcohol consumption leads to defects in hepatic protein trafficking. As described earlier, there is evidence that modification of tubulin and components of the clathrin machinery by reactive ethanol metabolites or post-translational modifications of the natural repertoire may explain the trafficking defects. The challenge that remains is twofold. First, the specific alcohol-induced adducts or modifications on tubulin and on clathrin coat components must be identified, confirmed and catalogued. Second, and perhaps more importantly, the cellular consequences of these modifications on hepatic protein trafficking must be defined. For example, does alcohol-induced tubulin adduction or hyperacetylation lead to altered binding of microtubule associated proteins and/or motors that in turn impairs vesicle motility? Does this impact secretion, membrane protein delivery and/or endocytosis? Similarly, do clathrin machinery modifications lead to altered coat assembly, receptor recruitment, vesicle formation and/or vesicle budding? Careful morphologic and biochemical methods will be needed to answer these very important questions. Once the specific mechanisms are defined, it will be important to determine the direct physiologic consequences of impaired protein trafficking in the alcoholic patient. For example, does impaired clathrin-mediated internalization lead to increased circulating cytokines and decreased vitamin B 12 absorption? Does this then lead to altered hepatic cytokine signaling and malnourishment in the alcoholic? It is also important to determine whether alcohol-induced defects in protein trafficking are specific to the hepatocyte or are a more general phenomenon observed in other cells of the liver and in other organs. Clearly, these hypotheses are in nascent form, and much is left to be done to test them. Continued research in this emerging field will not only increase our understanding of the pathogenesis of alcoholic liver disease, but may also provide novel therapeutic approaches to treatment.
